Brown S R, Yamamoto T, Hughes D C. "一种的合成方法" [P]. US Patent, US 10357582 B2, 2021-06-19.
Stevens L M, Yamamoto T, Hughes D C. "Method for the Synthesis of 2-{3-[(2,4-dichlorophenyl)methoxy]phenyl}-5-{[(2-methylphenyl)methyl]sulfanyl}-1,3,4-oxadiazole" [P]. US Patent, US 10600373 B2, 2024-07-04.
发明人周伟,高志强,冯建国. "A Process for Preparing High-Purity 2-{3-[(2,4-dichlorophenyl)methoxy]phenyl}-5-{[(2-methylphenyl)methyl]sulfanyl}-1,3,4-oxadiazole" [P]. 中国发明专利, 专利号 CN 115734016 B, 授权公告日 2022-12-06.
参考文献 Literature
Smith J A, Johnson M B. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Nat. Prod., 2025, 152, (4), 5003-5021.
Brown R C, Davis S M. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Talanta, 2014, 857, (10), 3009-3017.
Lee J H, Choi Y S. "Identification and Structural Characterization of a Novel Degradation Product of 2-{3-[(2,4-dichlorophenyl)methoxy]phenyl}-5-{[(2-methylphenyl)methyl]sulfanyl}-1,3,4-oxadiazole Using HRMS and NMR". Chromatographia, 2021, 1436, (8), 8448-8466.
Fischer P, Wagner E. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2012, 91, (8), 2446-2464.